Percutek Therapeutics Completed The Newest Round of Financing

Percutek Therapeutics just completed the newest round of 14 million dollars financing. This round of financing was led by General Technology VC and Jianxing Medical Funds, and followed by Everest Venture Capital and Insight Capital.

Percutek Therapeutics specializes in the research of cardiovascular disease, its main products are the "abdominal aortic stent graft system" and the "thoracic aortic stent graft system" for the treatment of aortic dissection and aortic aneurysm.

Percutek Therapeutics has developed products for the needs of Chinese patients, and has continued to develop more patented vascular implant interventional devices to improve its services.

General Technology Venture Capital is an investment firm focused on domestic and overseas investments and M&A projects.

Jianxing Medical Funds is a Chinese investment and asset management company.

Everest Venture Capital is an early stage venture capital fund that aims to invest and grow companies in China.

Insight Capital is a venture capital firm focused on early-stage investment in China.